25 July, 2017 by The TZ Newswire Staff Comments Off on There Is Only One Empire: Finance
There Is Only One Empire: Finance
By Charles Hugh Smith – Any nation-state that meets these four requirements is fully exposed to a global loss of faith in its economy, debt, a balance of payments and currency. There’s an entire sub-industry in journalism devoted to the idea…
25 July, 2017 by The TZ Newswire Staff Comments Off on Metals Stocks: Gold suffers a second session of losses as investors await Fed update
Metals Stocks: Gold suffers a second session of losses as investors await Fed update
Gold on Tuesday logs its first back-to-back decline in three weeks, while copper notched its highest finish in more than two years.
read more
25 July, 2017 by The TZ Newswire Staff Comments Off on In One Chart: The highest paid athletes in the world, in one chart
In One Chart: The highest paid athletes in the world, in one chart
This graphic shows who makes the most money from a combination of salary, winnings and endorsements.
read more
25 July, 2017 by The TZ Newswire Staff Comments Off on It was a record-setting week for people trying to take guns on planes
It was a record-setting week for people trying to take guns on planes
Most of the guns were loaded, the Brady Campaign said
read more
25 July, 2017 by The TZ Newswire Staff Comments Off on Stock Market Held Support on Monday
Stock Market Held Support on Monday
Welcome to TradingGods.net – Be A Trading God
The stock market indices started the day off with a little pop to resistance, they pulled back and held support the same as they have for the last three consecutive sessions.
The post Stock Market Held Support on Monday appeared first on TradingGods.net.
25 July, 2017 by The TZ Newswire Staff Comments Off on McDonalds Stock at All-Time Highs After Earnings
McDonalds Stock at All-Time Highs After Earnings
McDonald’s hit an all-time high after another solid quarter, solidifying its position as a Dow and broad market leader.
25 July, 2017 by The TZ Newswire Staff Comments Off on An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals
An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals (NASDAQ: AUPH), and now is working on another drug, Voclosporin, for the same indication.